Manatpreeprem Roongroj, Lerkvaleekul Butsabong, Vilaiyuk Soamarat
Rheumatology Division, Pediatric Department, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Front Pharmacol. 2023 May 5;14:1149320. doi: 10.3389/fphar.2023.1149320. eCollection 2023.
Failure to take medications regularly leads to poorer health outcomes. The Pediatric Rheumatology Adherence Questionnaire (PRAQ) is an effective tool for assessing medication adherence in rheumatic patients. Therefore, we aimed to determine the factors associated with poor medication adherence among children with rheumatic diseases. This was a cross-sectional study. Patients with rheumatic diseases who had taken at least one medication and had been followed up at our pediatric rheumatology clinic were included in the study, together with their caregivers. Patients with poor medication adherence were characterized as those who had taken less than 80% of their prescribed drugs, as determined using the pill count method. The original PRAQ was translated and validated in Thai language and was completed by caregivers and literate patients over age 13 years. Interviewing for additional problems with taking medications was conducted. We performed descriptive and logistic regression analyses. From 210 patients, 52.86% had juvenile idiopathic arthritis (JIA), and 46.19% had connective tissue diseases. The mean patient age was 14.10 ± 4.74 years, with a median (interquartile range) disease duration of 4.33 (2.08-6.98) years. PRAQ scores in the group with poor adherence were significantly higher than scores in the group with good adherence (11.00 ± 3.47 vs. 9.51 ± 3.16, = 0.004). Enthesitis-related arthritis (ERA) (odds ratio [OR] 9.09, 95% confidence interval [CI] 1.25-66.18; = 0.029) and polyarticular JIA (OR 6.43, 95% CI 1.30-31.75; = 0.022) were associated with poor treatment adherence. Disease duration ≥5 years (OR 3.88, 95% CI 1.17-12.87; = 0.027), active disease (OR 6.49, 95% CI 1.76-23.99; = 0.005), PRAQ scores ≥12 (OR 6.48, 95% CI 1.76-23.82; = 0.005), forgetting to take medications (OR 14.18, 95% CI 4.21-47.73; < 0.001), and unawareness about the importance of the medicines (OR 44.18, 95% CI 11.30-172.73; < 0.001) were predictors of poor drug adherence. In the present study, poor medication adherence was found in one-fourth of children with rheumatic illnesses, particularly those with ERA, polyarticular JIA, longer disease duration, active disease, and high PRAQ scores. The most frequent reasons for inadequate medication adherence were forgetfulness and unawareness about the importance of disease control and consistency with treatment.
不规律服药会导致更差的健康结果。儿童风湿病依从性问卷(PRAQ)是评估风湿病患者药物依从性的有效工具。因此,我们旨在确定风湿病患儿药物依从性差的相关因素。这是一项横断面研究。本研究纳入了在我们儿科风湿病门诊接受至少一种药物治疗并进行随访的风湿病患者及其照顾者。药物依从性差的患者定义为通过药丸计数法确定服用的处方药少于80%的患者。原始的PRAQ被翻译成泰语并进行了验证,由照顾者和13岁以上有读写能力的患者完成。针对服药的其他问题进行了访谈。我们进行了描述性分析和逻辑回归分析。在210名患者中,52.86%患有幼年特发性关节炎(JIA),46.19%患有结缔组织病。患者的平均年龄为14.10±4.74岁,疾病持续时间的中位数(四分位间距)为4.33(2.08 - 6.98)年。依从性差的组的PRAQ评分显著高于依从性好的组(11.00±3.47对9.51±3.16,P = 0.004)。附着点炎相关关节炎(ERA)(比值比[OR]9.09,95%置信区间[CI]1.25 - 66.18;P = 0.029)和多关节型JIA(OR 6.43,95%CI 1.30 - 31.75;P = 0.022)与治疗依从性差有关。疾病持续时间≥5年(OR 3.88,95%CI 1.17 - 12.87;P = 0.027)、疾病活动(OR 6.49,95%CI 1.76 - 23.99;P = 0.005)、PRAQ评分≥12(OR 6.48,95%CI 1.76 - 23.82;P = 0.005)、忘记服药(OR 14.18,95%CI 4.21 - 47.73;P < 0.001)以及未意识到药物的重要性(OR 44.18,95%CI 11.30 - 172.73;P < 0.001)是药物依从性差的预测因素。在本研究中,四分之一的风湿病患儿存在药物依从性差的情况,尤其是那些患有ERA、多关节型JIA、疾病持续时间较长、疾病活动以及PRAQ评分较高的患儿。药物依从性不足的最常见原因是遗忘以及未意识到疾病控制和治疗一致性的重要性。